DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that a UK subsidiary of Quantum Leap Energy LLC (“QLE”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has commenced a strategic collaboration with the University of Bristol for the design of a state-of-the-art lithium laser research facility in the UK. This collaboration marks a significan ...

ASP Isotopes stock is charging ahead with explosive momentum. What’s driving ASPI stock higher?Phase 1 Drilling Completed Ahead Of ScheduleThe drilling program reached the required cumulative nameplate flow rate, reducing execution risk as remaining work shifts primarily to engineering tasks.Results from the Phase 1 campaign indicate the reservoir system can deliver gas flow rates that meet or exceed prior estimates, addressing constraints that previously limited helium production and supporting more effici ...

DALLAS, March 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that the Company has completed the drilling of the wells required for Phase 1 of the Renergen Helium Project approximately four months ahead of schedule. “This marks a watershed moment for our plans for helium production at the Virginia ...

Summary of ASP Isotopes FY Conference Call Company Overview - **Company**: ASP Isotopes (NasdaqCM:ASPI) - **CEO**: Paul Mann - **Date of Conference**: March 12, 2026 Industry Context - **Helium Shortage**: A significant helium shortage is impacting semiconductor production and other industries, with 25%-30% of the world's helium supply currently offline due to production issues in Qatar [3][5][6]. - **Production Rates**: Current helium production is at approximately 4.5 billion cubic feet (BCF) annually, while demand is around 6.5 BCF, indicating a supply-demand gap [5]. Key Points on Helium Supply - **Geopolitical Factors**: The closure of the Strait of Hormuz and damage to Qatar's LNG facility have exacerbated the helium supply crisis [6]. - **ASP Isotopes' Role**: ASP Isotopes owns Renergen, which is expected to be one of the largest helium producers by the end of the decade. The company is currently in phase one of its helium liquefied natural gas plant build-out [6][7]. - **Production Capacity**: Phase one is projected to produce about 58 thousand cubic feet (MCF) of helium per day, with potential revenues of $8 million annually at current helium prices [10][12]. Financial Projections - **Revenue Estimates**: Combined annualized revenue from helium and LNG is estimated at $20 million, with gross profits around $5 million. Higher helium prices could significantly increase profits [10][11][12]. - **Government Support**: The U.S. government has deemed ASP's helium facilities critical, committing $500 million to phase two of the project [11][12]. Isotope Production Updates - **Silicon-28**: Initial samples shipped in August 2025 have been confirmed for quality. The plant is set to restart soon after implementing safety and efficiency improvements [21][23]. - **Carbon-14**: Feedstock from Canada is expected imminently, with production anticipated to start within 60-90 days [24][25]. - **Ytterbium-176**: Production is currently limited due to a laser failure, but operations are expected to ramp up to commercial volumes soon [28][29]. Regulatory and Strategic Developments - **Regulatory Advancements**: ASP has signed a service level agreement with the South African Nuclear Energy Corporation, allowing for uranium enrichment at an existing facility [34][35]. - **Partnerships**: Collaboration with TerraPower for uranium enrichment is ongoing, with a focus on meeting timelines for reactor fuel supply [38]. Strategic Vision - **Integration of Operations**: The acquisition of Renergen is seen as a strategic move to create a comprehensive electronic gases company, integrating helium production with semiconductor and medical isotope operations [40][41][42]. - **Future Growth**: ASP Isotopes aims to become a low-cost producer of isotopes by exploring locations with cheap energy for new plants, including Iceland and North America [52][53]. Conclusion - ASP Isotopes is positioned to play a critical role in addressing the helium supply crisis while expanding its isotope production capabilities. The company's strategic acquisitions and partnerships are aimed at enhancing its market position in the semiconductor and medical isotope sectors.

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of ASP Isotopes Inc. (NASDAQ: ASPI) towards shareholders [1] Group 1: Investigation Details - The investigation focuses on whether the actions of ASP Isotopes Inc. insiders have harmed shareholder interests [1] - Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation [1] Group 2: Shareholder Rights and Options - Long-term shareholders of ASP Isotopes may seek corporate governance reforms, return of funds, court-approved financial incentives, or other relief [1] - Participation of shareholders is emphasized as a means to improve company policies and enhance shareholder value [1] Group 3: Legal Representation - Halper Sadeh LLC represents investors globally who have experienced securities fraud and corporate misconduct, recovering millions for defrauded investors [1]

Group 1 - ASP Isotopes Inc. (NASDAQ:ASPI) has entered into a non-binding memorandum of understanding with a large publicly traded U.S. energy company that operates nuclear power stations, leading to a rise in its stock price [1] - ASP Isotopes shares have increased by 37.19% over the past 12 months, although they are currently closer to their 52-week low than their 52-week high [2] - The stock is trading 2.8% above its 20-day simple moving average (SMA) but remains 22.2% below its 100-day SMA, indicating a short-term bounce within a longer-term downtrend [2] Group 2 - The Relative Strength Index (RSI) is at 40.47, indicating neutral territory but leaning towards weakness, while the MACD shows a bullish configuration suggesting that downside momentum is easing [3] - The next major catalyst for ASP Isotopes' stock is expected to be the earnings report scheduled for March 30, 2026 [4] Group 3 - At the time of publication, ASP Isotopes shares were up 6.65% at $5.45, with key resistance identified at $6.50 and key support at $5.50 [5] - The earnings per share (EPS) estimate is a loss of 14 cents, which is a decline from a loss of 13 cents year-over-year, while the revenue estimate is $2.03 million, an increase from $1.19 million year-over-year [5]

Group 1: Acquisition Details - Centurium Capital acquired the high-end U.S. coffee chain Blue Bottle for less than $400 million from Nestle, significantly lower than the initial asking price of $700 million [1] - Nestle had previously acquired 68% of Blue Bottle in 2017 for $425 million and later bought out the entire chain, expanding its store count from around 30 to approximately 100 [2] - Blue Bottle operates not only in the U.S. but also in Canada, Japan, South Korea, and China, where it has 16 stores [2] Group 2: Market Positioning - Blue Bottle is positioned as a premium coffee brand, selling products in China for nearly 50 yuan per cup, while Luckin Coffee, in which Centurium holds a significant stake, targets the lower end of the market with prices ranging from 10 to 20 yuan [4] - Luckin Coffee has a much larger footprint with 30,000 stores, primarily in China, and has recently expanded globally [3] Group 3: Strategic Moves - Centurium has shown interest in the coffee sector, previously exploring partnerships with Starbucks and bids for Costa Coffee, although it did not secure these deals [5][6] - Centurium controls 44% of the voting power in Luckin Coffee, making it the controlling shareholder, but does not plan to integrate Blue Bottle with Luckin [4]

Core Insights - Maersk has temporarily suspended shipping services in the Middle East due to the ongoing conflict with Iran [1][2][3] - The suspension affects routes connecting the Far East to the Middle East and the Middle East to Europe, as well as shuttle services in the Gulf region [2][3] - The decision aims to ensure the safety of personnel and vessels while minimizing operational disruptions across Maersk's network [3] Industry Impact - The conflict has halted shipping traffic through the Strait of Hormuz, leading to significant delays and congestion, with 147 container ships currently stuck in the Persian Gulf [7] - This situation has resulted in higher prices and disruptions in global markets, as the Strait of Hormuz is a critical maritime chokepoint for oil and gas, accounting for about 20% of global flows [7] - The closure of such a chokepoint can significantly impact industries, disrupt revenue forecasts, and necessitate reevaluation of sourcing and logistics strategies [9]

Core Insights - The announcement marks a significant step towards enhancing the domestic supply chain for nuclear fuel in the United States through a non-binding Memorandum of Understanding (MOU) between Quantum Leap Energy LLC (QLE) and a major U.S. energy company [1][4] Group 1: MOU Details - The MOU involves the evaluation of options to support QLE's plans for establishing advanced nuclear fuel cycle facilities in the U.S., aimed at producing high assay low enriched uranium (HALEU) and low enriched uranium plus (LEU+) [2][3] - The agreement outlines potential financial support terms for the supply of enriched uranium, which is crucial for the development of these facilities [2] Group 2: Importance of HALEU and LEU+ - QLE emphasizes that HALEU and LEU+ are essential nuclear fuels for the U.S., particularly for advanced nuclear reactors, including small modular reactors [3] - The introduction of LEU+ is expected to extend the refueling intervals, reduce costs, and enhance power output for existing reactors currently using LEU [3] Group 3: Strategic Context - The MOU is timely, given the increasing urgency to boost U.S.-based uranium enrichment capacity, especially with the federal government's ban on Russian uranium imports set to begin in 2028 [4] - The collaboration highlights the need for reliable domestic sources of nuclear fuel to address the anticipated gap in the nuclear fuel supply chain due to rising demand from next-generation reactor developers [4] Group 4: Company Overview - Quantum Leap Energy is focused on advancing technologies across critical segments of the nuclear fuel cycle, including uranium conversion and enrichment [5] - The company holds exclusive global rights to proprietary technologies aimed at addressing gaps in the nuclear fuel supply chain for advanced nuclear reactors and fusion systems [5]

Core Insights - Quantum Leap Energy LLC, a subsidiary of ASP Isotopes Inc., has appointed Dr. Nate Salpeter as Chief Technology Officer to enhance its advanced energy technologies [1][7] Company Overview - Quantum Leap Energy is focused on innovative technologies and processes in the nuclear fuel cycle, including uranium conversion and radioactive waste treatment [8][9] - The company holds exclusive global rights to proprietary technologies such as the Aerodynamic Separation Process and laser-based Quantum Enrichment [9] Leadership and Expertise - Dr. Salpeter brings over 15 years of experience in energy technology optimization and has a strong background in computational fluid dynamics and engineering programs [2][4] - His previous roles include Systems Lead at TerraPower and Senior Advisor at Kairos Power, where he developed foundational computational frameworks [4][5] Strategic Goals - Dr. Salpeter's responsibilities will include optimizing existing technologies, implementing rapid learning cycles, and leading de-risking efforts to align with the company's strategic objectives [3][5] - The appointment is seen as a significant milestone for the company, expected to enhance its capabilities in advancing technologies toward commercialization [7]